Early Health Warning Intervention in Tobacco Control

Summary

This is a multi-center, randomized, controlled intervention clinical trial. A total of 1000 current smokers with rapid decline in lung function will be recruited and equally divided into two groups, comprehensive smoking cessation intervention group (early health warning intervention combined with brief smoking cessation intervention) and brief smoking cessation intervention group. It is aimed to evaluate whether early health warning intervention will increase the rate of smoking cessation.

Conditions

• Smoking Cessation

Interventions

OTHER

early health warning intervention

early health warning intervention is to tell the subjects that smoking leads to the rapid decline of their lung function, and they are at the high risk of developing COPD.

Sponsors & Collaborators

• The Second Hospital of Hebei Medical University

  collaborator OTHER

• Henan Provincial People's Hospital

  collaborator OTHER

• Second Hospital of Jilin University

  collaborator OTHER

• First Affiliated Hospital Xi'an Jiaotong University

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• Shanxi Bethune Hospital

  collaborator OTHER

• Tianjin Medical University General Hospital

  collaborator OTHER

• The Affiliated Hospital of Inner Mongolia Medical University

  collaborator OTHER

• The First Hospital of Qinhuangdao

  collaborator OTHER_GOV

• Peking University First Hospital

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2021-04-21

Primary Completion

2022-12-31

Completion

2022-12-31

Countries

• China

Study Locations